Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 6 minute read Pharma Industry News Sanofi’s second chance: Why Europe is warming up to Rezurock after initial CHMP rejection Sanofi’s Rezurock secures EU conditional approval recommendation for chronic GVHD. Find out what changed and how this could reshape rare disease care. byPallavi MadhirajuFebruary 2, 2026